Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

353 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hydration with magnesium and mannitol without furosemide prevents the nephrotoxicity induced by cisplatin and pemetrexed in patients with advanced non-small cell lung cancer.
Muraki K, Koyama R, Honma Y, Yagishita S, Shukuya T, Ohashi R, Takahashi F, Kido K, Iwakami S, Sasaki S, Iwase A, Takahashi K. Muraki K, et al. Among authors: yagishita s. J Thorac Dis. 2012 Dec;4(6):562-8. doi: 10.3978/j.issn.2072-1439.2012.10.16. J Thorac Dis. 2012. PMID: 23205279 Free PMC article.
Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
Nurwidya F, Takahashi F, Kobayashi I, Murakami A, Kato M, Minakata K, Nara T, Hashimoto M, Yagishita S, Baskoro H, Hidayat M, Shimada N, Takahashi K. Nurwidya F, et al. Among authors: yagishita s. Biochem Biophys Res Commun. 2014 Dec 12;455(3-4):332-8. doi: 10.1016/j.bbrc.2014.11.014. Epub 2014 Nov 15. Biochem Biophys Res Commun. 2014. PMID: 25446090
Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agents.
Shukuya T, Ko R, Mori K, Kato M, Yagishita S, Kanemaru R, Honma Y, Shibayama R, Koyama R, Shimada N, Takahashi K. Shukuya T, et al. Among authors: yagishita s. Cancer Chemother Pharmacol. 2015 Oct;76(4):771-6. doi: 10.1007/s00280-015-2843-3. Epub 2015 Aug 11. Cancer Chemother Pharmacol. 2015. PMID: 26259641 Clinical Trial.
Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells.
Kobayashi I, Takahashi F, Nurwidya F, Nara T, Hashimoto M, Murakami A, Yagishita S, Tajima K, Hidayat M, Shimada N, Suina K, Yoshioka Y, Sasaki S, Moriyama M, Moriyama H, Takahashi K. Kobayashi I, et al. Among authors: yagishita s. Biochem Biophys Res Commun. 2016 Apr 22;473(1):125-132. doi: 10.1016/j.bbrc.2016.03.064. Epub 2016 Mar 17. Biochem Biophys Res Commun. 2016. PMID: 26996130
LSD1/KDM1 isoform LSD1+8a contributes to neural differentiation in small cell lung cancer.
Jotatsu T, Yagishita S, Tajima K, Takahashi F, Mogushi K, Hidayat M, Wirawan A, Ko R, Kanemaru R, Shimada N, Mitani K, Saito T, Takamochi K, Suzuki K, Kohsaka S, Kojima S, Mukae H, Yatera K, Takahashi K. Jotatsu T, et al. Among authors: yagishita s. Biochem Biophys Rep. 2016 Dec 1;9:86-94. doi: 10.1016/j.bbrep.2016.11.015. eCollection 2017 Mar. Biochem Biophys Rep. 2016. PMID: 28955993 Free PMC article.
Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.
Kanemaru R, Takahashi F, Kato M, Mitsuishi Y, Tajima K, Ihara H, Hidayat M, Wirawan A, Koinuma Y, Hayakawa D, Yagishita S, Ko R, Sato T, Harada N, Kodama Y, Nurwidya F, Sasaki S, Niwa SI, Takahashi K. Kanemaru R, et al. Among authors: yagishita s. Lung. 2018 Oct;196(5):531-541. doi: 10.1007/s00408-018-0134-6. Epub 2018 Jun 20. Lung. 2018. PMID: 29926178
353 results